Skip to main content
TELA
NASDAQ Industrial Applications And Services

TELA Bio Slashes Workforce by 20% and Loses CFO Amid Going-Concern Crisis

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.661
Mkt Cap
$31.426M
52W Low
$0.501
52W High
$1.87
52W Position info
32% above low
Off High info
65% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

TELA sits 32% above its 52-week low of $0.501.

Summary

TELA Bio announced a 20% workforce reduction and the departure of CFO/COO Roberto Cuca, part of a $17 million annual cost-cutting initiative aimed at extending cash runway into 2028.


Key Events · Executive and Board Changes · TELA

  • 20% Workforce Reduction

    Headcount is being reduced from 201 to 160 full-time employees, with the cuts expected to be substantially completed during Q3 2026.

  • $17M Annual Cost Savings

    The company expects to reduce annual operating expenses by $17.0 million (18%) through headcount cuts and streamlining external resources.

  • CFO/COO Departure

    Roberto Cuca stepped down as CFO, COO, Corporate Secretary, and principal financial officer effective August 31, 2026; CEO Heather Getz has been appointed principal financial officer.

  • Cash Runway Extended to 2028

    Management expects the cost reduction initiative to extend cash runway into 2028, addressing near-term liquidity concerns.


Analysis · TELA · Industrial Applications And Services

Weeks after warning of a potential debt covenant breach and raising substantial doubt about its ability to continue as a going concern, TELA Bio is cutting 20% of its workforce and losing its CFO/COO. The $17 million annual cost reduction is a survival move that extends cash runway into 2028, but the simultaneous departure of the CFO and the scale of the layoffs underscore the severity of the company's financial distress. The restructuring charge of $1.5 million is modest relative to the savings, but the loss of the CFO during a covenant crisis adds execution risk.

How filings like this one have moved

In the 30 days to Sep 13, 2026, 35.6% of the 1216 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TELA was trading at $0.66 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $31.4M. The 52-week trading range was $0.50 to $1.87. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TELA - Latest Insights

TELA
Sep 04, 2026, 4:05 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.8215
Real-time Price: $0.9551 info
Change: +$0.1336 (+16%) info
Market Cap: $43.548M info
TELA
Aug 11, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.790
Real-time Price: $0.9551 info
Change: +$0.1651 (+21%) info
Market Cap: $43.548M info
TELA
Aug 10, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.930
Real-time Price: $0.9551 info
Change: +$0.0251 (+3%) info
Market Cap: $43.548M info
TELA
Aug 10, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.9135
Real-time Price: $0.9551 info
Change: +$0.0416 (+5%) info
Market Cap: $43.548M info
TELA
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.8699
Real-time Price: $0.9551 info
Change: +$0.0852 (+10%) info
Market Cap: $43.548M info